Literature DB >> 22473731

A self-help coping intervention can reduce anxiety and avoidant health behaviours whilst waiting for cancer genetic risk information: results of a phase III randomised trial.

Ceri Phelps1, Paul Bennett, Kerenza Hood, Kate Brain, Alexandra Murray.   

Abstract

OBJECTIVE: The objective of this study is to evaluate the effectiveness of a self-help coping intervention in reducing intrusive negative thoughts while waiting for cancer genetic risk information.
METHODS: Between August 2007 and November 2008, 1958 new referrals for cancer genetic risk assessment were invited to participate in a randomised trial. The control group received standard information. The intervention group received this information plus a written self-help coping leaflet. The primary outcome measure was the intrusion subscale of the Impact of Event Scale.
RESULTS: The intervention significantly reduced intrusive thoughts during the waiting period in those reporting moderate baseline levels of intrusion (p = 0.03). Following risk provision, those in the intervention group reporting low and moderate intrusive worries at baseline reported less intrusive thoughts than those in the control group (p = 0.04 and p = 0.03, respectively). The intervention had no adverse impact in the sample as a whole. Participants in the intervention group with high baseline avoidance and negative affect scores were significantly more likely to remain in the study than those in the control group (p = 0.05 and p = 0.004).
CONCLUSIONS: Findings that the intervention both reduced distress in those with moderate levels of distress and had no adverse effects following notification of cancer genetic risk suggest that this simple intervention can be implemented across a range of oncology settings involving periods of waiting and uncertainty. The intervention may also reduce the number of individuals dropping out of cancer genetic risk assessment or screening. However, those with clinically high levels of psychological distress are likely to require a more intensive psychological intervention.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22473731     DOI: 10.1002/pon.3072

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  6 in total

1.  Effects of genetic and environmental risk assessment feedback on colorectal cancer screening adherence.

Authors:  Ronald E Myers; Karen Ruth; Sharon L Manne; James Cocroft; Randa Sifri; Barry Ziring; Desiree Burgh; Eric Ross; David S Weinberg
Journal:  J Behav Med       Date:  2015-03-18

2.  The PRCI study: design of a randomized clinical trial to evaluate a coping intervention for medical waiting periods used by women undergoing a fertility treatment.

Authors:  Henrietta D L Ockhuijsen; Agnes van den Hoogen; Nickolas S Macklon; Jacky Boivin
Journal:  BMC Womens Health       Date:  2013-09-03       Impact factor: 2.809

3.  The effect of a positive reappraisal coping intervention and problem-solving skills training on coping strategies during waiting period of IUI treatment: An RCT.

Authors:  Marzieh Ghasemi; Masoumeh Kordi; Negar Asgharipour; Habibollah Esmaeili; Maliheh Amirian
Journal:  Int J Reprod Biomed       Date:  2017-11

4.  Smartphone-supported Positive Adjustment Coping Intervention (PACI) for couples undergoing fertility treatment: a randomised controlled trial protocol.

Authors:  Maren Schick; Sabine Roesner; Ariane Germeyer; Markus Moessner; Stephanie Bauer; Beate Ditzen; Tewes Wischmann
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

5.  Psychosocial impact of prognostic genetic testing in uveal melanoma patients: a controlled prospective clinical observational study.

Authors:  Marietta Lieb; Sefik Tagay; Anja Breidenstein; Tobias Hepp; Claudia H D Le Guin; Jennifer Scheel; Dietmar R Lohmann; Norbert Bornfeld; Martin Teufel; Yesim Erim
Journal:  BMC Psychol       Date:  2020-01-31

6.  Psychosocial impact of prognostic genetic testing in the care of uveal melanoma patients: protocol of a controlled prospective clinical observational study.

Authors:  Yesim Erim; Jennifer Scheel; Anja Breidenstein; Claudia Hd Metz; Dietmar Lohmann; Hans-Christoph Friederich; Sefik Tagay
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.